Literature DB >> 5316677

The effects of perfusing the perilymphatic space with artificial endolymph.

H Silverstein.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 5316677     DOI: 10.1177/000348947007900408

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


× No keyword cloud information.
  8 in total

1.  Effect of the high potassium medium on cultured cochlear epithelial cells.

Authors:  Y Okano; H Iwai
Journal:  Arch Otorhinolaryngol       Date:  1975

2.  Pathophysiology of endolymphatic hydrops.

Authors:  H F Schuknecht
Journal:  Arch Otorhinolaryngol       Date:  1976-09-16

3.  Ionic mechanism of the efferent olivo-cochlear inhibition studied by cochlear perfusion in the cat.

Authors:  J E Desmedt; D Robertson
Journal:  J Physiol       Date:  1975-05       Impact factor: 5.182

4.  Behavior of the nystagmus in Menière's attack.

Authors:  R Meissner
Journal:  Arch Otorhinolaryngol       Date:  1981

5.  The effect of changes in perilymphatic K+ on the vestibular evoked potential in the guinea pig.

Authors:  C M Kingma; H P Wit
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06-09       Impact factor: 2.503

6.  Transitory endolymph leakage induced hearing loss and tinnitus: depolarization, biphasic shortening and loss of electromotility of outer hair cells.

Authors:  H P Zenner; G Reuter; U Zimmermann; A H Gitter; C Fermin; E L LePage
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

7.  K+-induced motility and depolarization of cochlear hair cells. Direct evidence for a new pathophysiological mechanism in Ménière's disease.

Authors:  H P Zenner
Journal:  Arch Otorhinolaryngol       Date:  1986

8.  Recent and Frequent Vertigo Attacks Produce Negative Findings on Furosemide-Loading Vestibular Evoked Myogenic Potential Testing in Meniere's Disease.

Authors:  Toru Seo; Ko Shiraishi; Takaaki Kobayashi; Takeshi Fujita; Kazuya Saito; Katsumi Doi
Journal:  Front Neurol       Date:  2018-08-03       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.